FDA Approves New Thyroid Cancer Treatment
The FDA's approval of a targeted therapeutic called lenvatinib provides another option for patients certain forms of thyroid cancer.
Progress Against Cancer
The FDA's approval of a targeted therapeutic called lenvatinib provides another option for patients certain forms of thyroid cancer.
The FDA has approved of a treatment for Waldenström's macroglobulinemia, a rare form of non-Hodgkin lymphoma. Learn more.
The FDA recently approved new therapeutics for acute lymphoblastic leukemia, metastatic melanoma, and advanced ovarian cancer. In December 2014, the U.S. Food and Drug Administration (FDA) issued three approvals for new medications to treat...
The FDA recently approved a new HPV vaccine that could prevent up to 90 percent of cervical cancers in the U.S. In late 2014, the U.S. Food and Drug Administration (FDA) announced the approval...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More